Oral Solid Dosage Forms

Tablets & capsules, General and Beta-Lactam

India has emerged as one of the leading players in the global pharmaceutical industry, particularly in the manufacturing of Oral Solid Dosage forms — valued for their stability, ease of administration and patient compliance.

Dedicated Facilities

General & Beta-Lactam production, kept separate

Sai Sarvaa Biotech Private Limited maintains dedicated facilities for General and Beta-Lactam products, using established QC instrumentation at every stage. Our core strategy is to focus on high barriers of entry — innovation and timely execution of the business plan sit at the centre of how we manufacture.

The company's pipeline of Oral Solid Dosage forms covers tablets and capsules across both product families, produced to meet global regulatory expectations including those of the FDA and EMA, and in full compliance with WHO Good Manufacturing Practices.

Generic medicines
Over-the-counter (OTC) formulations
Specialised therapeutic formulations

Tablet compression at Sai Sarvaa Biotech

Therapeutic Segments

Formulations across nine therapeutic areas

Our extensive product portfolio caters to a wide range of healthcare needs, both in India and abroad.

Antibiotics

General and Beta-Lactam anti-infective formulations.

Gastro-Intestinal

Formulations for digestive and gastro-intestinal care.

Anti-Allergic

Relief-focused formulations for allergic conditions.

Anti-Fungal

Targeted anti-fungal oral solid dosage forms.

Cardiovascular

Formulations supporting heart and circulatory health.

Nutritional

Nutritional supplements in tablet and capsule form.

NSAIDs

Non-steroidal anti-inflammatory formulations.

Ortho

Formulations supporting bone and joint health.

Gynaecological

Formulations addressing women's health needs.

Research & Development

Improving bioavailability, without compromising safety

Continuous formulation R&D

Our dedicated R&D team works on improving the bioavailability and efficacy of tablets and capsules while ensuring patient safety, continuously investing in new formulations and drug-delivery systems.

International presence

Sai Sarvaa Biotech Private Limited exports its products to numerous countries, including regulated markets, through strategic partnerships with international distributors and healthcare providers.